Search Results

There are 3735 results for: content related to: Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy

  1. Pre-treatment carbohydrate antigen 19-9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer

    HPB

    Volume 17, Issue 10, October 2015, Pages: 942–952, Mohammed Aldakkak, Kathleen K. Christians, Ashley N. Krepline, Ben George, Paul S. Ritch, Beth A. Erickson, Fabian M. Johnston, Douglas B. Evans and Susan Tsai

    Version of Record online : 10 AUG 2015, DOI: 10.1111/hpb.12448

  2. CA19-9 as a predictor of recurrence in patients with colorectal cancer

    Journal of Surgical Oncology

    Volume 66, Issue 4, December 1997, Pages: 238–243, Takamori Nakayama, Masahiko Watanabe, Tatsuo Teramoto and Masaki Kitajima

    Version of Record online : 7 DEC 1998, DOI: 10.1002/(SICI)1096-9098(199712)66:4<238::AID-JSO3>3.0.CO;2-C

  3. You have free access to this content
    A preoperative serum signature of CEA+/CA125+/CA19-9 ≥ 1000 U/mL indicates poor outcome to pancreatectomy for pancreatic cancer

    International Journal of Cancer

    Volume 136, Issue 9, 1 May 2015, Pages: 2216–2227, Liang Liu, Huaxiang Xu, Wenquan Wang, Chuntao Wu, Yong Chen, Jingxuan Yang, Putao Cen, Jin Xu, Chen Liu, Jiang Long, Sushovan Guha, Deliang Fu, Quanxing Ni, Aminah Jatoi, Suresh Chari, Angela L. McCleary-Wheeler, Martin E. Fernandez-Zapico, Min Li and Xianjun Yu

    Version of Record online : 18 OCT 2014, DOI: 10.1002/ijc.29242

  4. You have free access to this content
    Carbohydrate antigen 19·9 accurately selects patients for laparoscopic assessment to determine resectability of pancreatic malignancy

    British Journal of Surgery

    Volume 95, Issue 4, April 2008, Pages: 453–459, C. M. Halloran, P. Ghaneh, S. Connor, R. Sutton, J. P. Neoptolemos and M. G. T. Raraty

    Version of Record online : 28 DEC 2007, DOI: 10.1002/bjs.6043

  5. You have free access to this content
    Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer

    International Journal of Cancer

    Volume 131, Issue 3, 1 August 2012, Pages: 683–691, Jianqiang Liu, Jun Gao, Yiqi Du, Zhaoshen Li, Yan Ren, Junjun Gu, Xiaowei Wang, Yanfang Gong, Weiwei Wang and Xiangyu Kong

    Version of Record online : 19 NOV 2011, DOI: 10.1002/ijc.26422

  6. Prognostic significance of serum CA19-9 levels in resected pancreatic cancer

    Journal of Hepato-Biliary-Pancreatic Surgery

    Volume 3, Issue 1, March 1996, Pages: 66–70, Koji Fujimoto, Shunzou Koizumi, Satoru Nishimura, Satoaki Sakai, Yoshinori Nakamura, Satoru Matsusue, Hideo Tanaka, Hiroshi Takeda and Masayuki Imamura

    Version of Record online : 1 MAR 1996, DOI: 10.1007/BF01212783

  7. You have full text access to this Open Access content
    Clinical significance of serum levels of immune-associated molecules, uric acid and soluble MHC class I chain-related molecules A and B, as diagnostic tumor markers for pancreatic ductal adenocarcinoma

    Cancer Science

    Volume 102, Issue 9, September 2011, Pages: 1673–1679, Hye Won Chung and Jong-Baeck Lim

    Version of Record online : 3 JUL 2011, DOI: 10.1111/j.1349-7006.2011.01989.x

  8. You have full text access to this OnlineOpen article
    Decreased serum CA19-9 is associated with improvement of insulin resistance and metabolic control in patients with obesity and type 2 diabetes after Roux-en-Y gastric bypass

    Journal of Diabetes Investigation

    Volume 5, Issue 6, November 2014, Pages: 694–700, Yinfang Tu, Haoyong Yu, Pin Zhang, Jianzhong Di, Xiaodong Han, Songhua Wu, Yuqian Bao and Weiping Jia

    Version of Record online : 26 FEB 2014, DOI: 10.1111/jdi.12200

  9. Role of serum carbohydrate antigen 19-9 and carcinoembryonic antigen in distinguishing between benign and invasive intraductal papillary mucinous neoplasm of the pancreas

    British Journal of Surgery

    Volume 98, Issue 1, January 2011, Pages: 104–110, S. Fritz, T. Hackert, U. Hinz, W. Hartwig, M. W. Büchler and J. Werner

    Version of Record online : 14 OCT 2010, DOI: 10.1002/bjs.7280

  10. An elevated preoperative serum carbohydrate antigen 19-9 level is a significant predictor for peritoneal dissemination and poor survival in colorectal cancer

    Colorectal Disease

    Volume 17, Issue 5, May 2015, Pages: 417–425, Y. Takakura, S. Ikeda, Y. Imaoka, T. Urushihara and T. Itamoto

    Version of Record online : 21 APR 2015, DOI: 10.1111/codi.12865

  11. Clinical implication of serum carcinoembryonic antigen and carbohydrate antigen 19-9 for the prediction of malignancy in intraductal papillary mucinous neoplasm of pancreas

    Journal of Hepato-Biliary-Pancreatic Sciences

    Volume 22, Issue 9, September 2015, Pages: 699–707, Jae Ri Kim, Jin-Young Jang, Mee Joo Kang, Taesung Park, Seung Yeoun Lee, Woohyun Jung, Jihoon Chang, Youngchan Shin, Youngmin Han and Sun-Whe Kim

    Version of Record online : 14 JUL 2015, DOI: 10.1002/jhbp.275

  12. Retrospective evaluation of tumor markers in ovarian mature cystic teratoma and ovarian endometrioma

    Journal of Obstetrics and Gynaecology Research

    Volume 38, Issue 8, August 2012, Pages: 1071–1076, Taeko Kataoka, Yoh Watanabe and Hiroshi Hoshiai

    Version of Record online : 8 MAY 2012, DOI: 10.1111/j.1447-0756.2011.01833.x

  13. Immunohistochemical studies on the localization of cancer associated antigens DU-PAN-2 and CA19-9 in carcinomas of the digestive tract

    Journal of Gastroenterology and Hepatology

    Volume 5, Issue 1, February 1990, Pages: 25–31, G. OHSHIO, K. OGAWA, H. KUDO, H. YAMABE, Y. NAKASHIMA, Y. C. KIM, K. ENDO, Y. WATANABE, T. MANABE and T. TOBE

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1440-1746.1990.tb01764.x

  14. Elevated CA19-9 as the most significant prognostic factor in advanced colorectal carcinoma

    Journal of Surgical Oncology

    Volume 49, Issue 2, February 1992, Pages: 78–85, Mauri Kouri, Seppo Pyrhönen and Pentti Kuusela

    Version of Record online : 20 JUL 2006, DOI: 10.1002/jso.2930490204

  15. You have free access to this content
    Measurement of a monoclonal-antibody-defined antigen (CA 19-9) in the sera of patients with malignant and nonmalignant diseases comparison with carcinoembryonic antigen

    Cancer

    Volume 56, Issue 2, 15 July 1985, Pages: 277–283, Manjula K. Gupta, Rose Arciaga, Lewis Bocci, Raymond Tubbs, Ronald Bukowski and Sharad D. Deodhar

    Version of Record online : 29 JUN 2006, DOI: 10.1002/1097-0142(19850715)56:2<277::AID-CNCR2820560213>3.0.CO;2-M

  16. Marked elevation of CA19-9 in a patient with idiopathic pulmonary fibrosis: CA19-9 as a bad prognostic factor

    Respirology

    Volume 3, Issue 3, September 1998, Pages: 211–214, Jiro FUJITA, Yuka OBAYASHI, Ichiro YAMADORI, Yuji OHTSUKI, Hiroshi MIYAWAKI, Satoko HOJO, Yoko FURUKAWA and Jiro TAKAHARA

    Version of Record online : 18 FEB 2008, DOI: 10.1111/j.1440-1843.1998.tb00124.x

  17. Serum Levels of CA19-9 in patients with nonmalignant respiratory diseases

    Journal of Clinical Laboratory Analysis

    Volume 21, Issue 2, 2007, Pages: 103–106, Takahide Kodama, Hiroaki Satoh, Hiroichi Ishikawa and Morio Ohtsuka

    Version of Record online : 26 MAR 2007, DOI: 10.1002/jcla.20136

  18. Immunohistochemical analysis of CA125, CA19-9, and Ki-67 in stage III or IV endometriosis:

    Acta Obstetricia et Gynecologica Scandinavica

    Volume 79, Issue 9, September 2000, Pages: 771–776, TOSHIHIKO TOKI, JUNKO KUBOTA, XIN LU and KUNIAKI NAKAYAMA

    Version of Record online : 24 DEC 2001, DOI: 10.1034/j.1600-0412.2000.079009771.x

  19. Urinary bladder urothelial carcinoma with concurrent plasmacytoid and micropapillary differentiations: A report of two cases with an emphasis on serum carbohydrate antigen 19-9

    Pathology International

    Volume 65, Issue 9, September 2015, Pages: 495–500, Naohiro Makise, Teppei Morikawa, Yuta Takeshima, Tetsuya Fujimura, Yukio Homma and Masashi Fukayama

    Version of Record online : 4 JUN 2015, DOI: 10.1111/pin.12314

  20. You have free access to this content
    CA19-9 Does Not Predict cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis Undergoing Liver Transplantion

    Liver Transplantation and Surgery

    Volume 1, Issue 2, March 1995, Pages: 94–98, Adrian Fisher, Neil D. Theise, Albert Min, Eytan Mor, Sukru Emre, Adam Pearl, Myron E. Schwartz, Charles M. Miller and Patricia A. Sheiner

    Version of Record online : 15 DEC 2005, DOI: 10.1002/lt.500010204